Active Ingredient(s): Romosozumab-aqqg
FDA Approved: * April 9, 2019
Pharm Company: * AMGEN INC
Category: Osteoporosis

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Evenity Overview

Romosozumab, sold under the brand name Evenity, is a medication used to treat osteoporosis.[1] It has been found to decrease the risk of fractures of the spine.[1] Common side effect include headache, joint pain, and pain at the site of injection.[1] It may increase the risk of heart attacks, strokes, and deaths from cardiovascular disease.[1] It is a humanized monoclonal antibody that targets sclerostin.[2] Rese...

Read more Evenity Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Romosozumab

Recent Evenity Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

  • Injection: 105mg/1.17ml
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Evenity: (1 result)

Sorted by National Drug Code
  • 55513-880 Evenity 105 mg/1.17ml Subcutaneous Injection, Solution by Amgen Inc

Other drugs which contain Romosozumab-aqqg or a similar ingredient: (1 result)